Showing results (2571-2580 of 45,231) with videos related to
Sort By:
Pageof 4,524
Cancer Research|June 17, 2010
RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma modelsHong Yang, Brian Higgins, Kenneth Kolinsky, et al.Cancer Research|April 1, 1978
Abrogation of tumor rejection by trypan blueJ W Kreider, G L Bartlett, E DeFreitasCancer Research|July 9, 2010
A useful approach to identify novel small-molecule inhibitors of Wnt-dependent transcriptionKenneth Ewan, Bozena Pajak, Mark Stubbs, et al.Cancer Research|July 9, 2010
GlcNAcylation plays an essential role in breast cancer metastasisYuchao Gu, Wenyi Mi, Yuqing Ge, et al.Cancer Research|July 16, 2010
Vorinostat and sorafenib increase CD95 activation in gastrointestinal tumor cells through a Ca(2+)-de novo ceramide-PP2A-reactive oxygen species-dependent signaling pathwayMargaret A Park, Clint Mitchell, Guo Zhang, et al.Cancer Research|July 16, 2010
FOXO3 encodes a carcinogen-activated transcription factor frequently deleted in early-stage lung adenocarcinomaOliver R Mikse, Daniel C Blake, Nathan R Jones, et al.Cancer Research|July 16, 2010
HERC2 is an E3 ligase that targets BRCA1 for degradationWenwen Wu, Ko Sato, Ayaka Koike, et al.Cancer Research|July 28, 2010
Spi-1/PU.1 oncogene accelerates DNA replication fork elongation and promotes genetic instability in the absence of DNA breakagePauline Rimmelé, Jun Komatsu, Philippe Hupé, et al.Cancer Research|July 31, 2010
The ITK-SYK fusion oncogene induces a T-cell lymphoproliferative disease in mice mimicking human diseaseChristine Dierks, Francisco Adrian, Paul Fisch, et al.Cancer Research|August 5, 2010
Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinomaEmilia Albesiano, Meghan Davis, Alfred P See, et al.Pageof 4,524